Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Zai Lab Community
NasdaqGM:ZLAB Community
1
Narratives
written by author
0
Comments
on narratives written by author
13
Fair Values set
on narratives written by author
Create a narrative
Zai Lab
Latest
Undervalued
Overvalued
Community Investing Ideas
Zai Lab
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
China's Rising Healthcare Spending And Aging Demographics Will Fuel Future Pharmaceutical Breakthroughs
Key Takeaways Expansion into China’s growing healthcare market and a robust drug pipeline position the company for sustained revenue and earnings growth. Operational efficiencies through regulatory harmonization, manufacturing localization, and global collaborations are expected to boost profitability and margins.
View narrative
US$55.39
FV
37.6% undervalued
intrinsic discount
49.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
ZLAB
ZLAB
Zai Lab
Your Fair Value
US$
Current Price
US$34.55
10.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-554m
2b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.6b
Earnings US$306.8m
Advanced
Set Fair Value